Insud Pharma donation and assistance – Ukraine war situationMiguel Martínez-Cava2022-03-07T11:42:35+01:00March 7, 2022|News|
mAbxience launches its CDMO platform to third partiesMiguel Martínez-Cava2022-02-28T13:45:56+01:00February 28, 2022|News|
mAbxience’s biosimilar approved in JapanMiguel Martínez-Cava2022-02-23T15:39:52+01:00February 23, 2022|News|